136 related articles for article (PubMed ID: 2551719)
1. Studies on the potential neurotoxic and convulsant effects of increased blood levels of quinolinic acid in rats with altered blood-brain barrier permeability.
Vezzani A; Stasi MA; Wu HQ; Castiglioni M; Weckermann B; Samanin R
Exp Neurol; 1989 Oct; 106(1):90-8. PubMed ID: 2551719
[TBL] [Abstract][Full Text] [Related]
2. Quinolinic acid-induced seizures, but not nerve cell death, are associated with extracellular Ca2+ decrease assessed in the hippocampus by brain dialysis.
Vezzani A; Wu HQ; Angelico P; Stasi MA; Samanin R
Brain Res; 1988 Jun; 454(1-2):289-97. PubMed ID: 2970276
[TBL] [Abstract][Full Text] [Related]
3. Seizure activity and lesions after intrahippocampal quinolinic acid injection.
Schwarcz R; Brush GS; Foster AC; French ED
Exp Neurol; 1984 Apr; 84(1):1-17. PubMed ID: 6705878
[TBL] [Abstract][Full Text] [Related]
4. In vivo brain dialysis of amino acids and simultaneous EEG measurements following intrahippocampal quinolinic acid injection: evidence for a dissociation between neurochemical changes and seizures.
Vezzani A; Ungerstedt U; French ED; Schwarcz R
J Neurochem; 1985 Aug; 45(2):335-44. PubMed ID: 3159848
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant drugs effective against human temporal lobe epilepsy prevent seizures but not neurotoxicity induced in rats by quinolinic acid: electroencephalographic, behavioral and histological assessments.
Vezzani A; Wu HQ; Tullii M; Samanin R
J Pharmacol Exp Ther; 1986 Oct; 239(1):256-63. PubMed ID: 2945004
[TBL] [Abstract][Full Text] [Related]
6. Effect of intrahippocampal quinolinic acid infusion on the amygdala kindling in rat.
Ping HX; Liu GQ; Xie L; Wu HQ
Zhongguo Yao Li Xue Bao; 1991 Jul; 12(4):304-7. PubMed ID: 1807077
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of seizures induced by the administration of the endogenous convulsant quinolinic acid into rat brain ventricles.
Lapin IP; Prakhie IB; Kiseleva IP
J Neural Transm; 1986; 65(3-4):177-85. PubMed ID: 2940335
[TBL] [Abstract][Full Text] [Related]
8. The organotypic tissue culture model of corticostriatal system used for examining amino acid neurotoxicity and its antagonism: studies on kainic acid, quinolinic acid and (-) 2-amino-7-phosphonoheptanoic acid.
Whetsell WO; Schwarcz R
J Neural Transm Suppl; 1983; 19():53-63. PubMed ID: 6321650
[TBL] [Abstract][Full Text] [Related]
9. Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid.
Foster AC; Vezzani A; French ED; Schwarcz R
Neurosci Lett; 1984 Aug; 48(3):273-8. PubMed ID: 6237279
[TBL] [Abstract][Full Text] [Related]
10. Studies on the disposition of quinolinic acid after intracerebral or systemic administration in the rat.
Foster AC; Miller LP; Oldendorf WH; Schwarcz R
Exp Neurol; 1984 May; 84(2):428-40. PubMed ID: 6232146
[TBL] [Abstract][Full Text] [Related]
11. Differential action of NMDA antagonists on cholinergic neurotoxicity produced by N-methyl-D-aspartate and quinolinic acid.
Pawley AC; Flesher S; Boegman RJ; Beninger RJ; Jhamandas KH
Br J Pharmacol; 1996 Mar; 117(6):1059-64. PubMed ID: 8882597
[TBL] [Abstract][Full Text] [Related]
12. On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acids and structurally related compounds.
Foster AC; Collins JF; Schwarcz R
Neuropharmacology; 1983 Dec; 22(12A):1331-42. PubMed ID: 6229703
[TBL] [Abstract][Full Text] [Related]
13. Brain and plasma quinolinic acid in profound insulin-induced hypoglycemia.
Heyes MP; Papagapiou M; Leonard C; Markey SP; Auer RN
J Neurochem; 1990 Mar; 54(3):1027-33. PubMed ID: 1689373
[TBL] [Abstract][Full Text] [Related]
14. The neurotoxic actions of quinolinic acid in the central nervous system.
el-Defrawy SR; Boegman RJ; Jhamandas K; Beninger RJ
Can J Physiol Pharmacol; 1986 Mar; 64(3):369-75. PubMed ID: 2939936
[TBL] [Abstract][Full Text] [Related]
15. Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients.
Heyes MP; Brew BJ; Saito K; Quearry BJ; Price RW; Lee K; Bhalla RB; Der M; Markey SP
J Neuroimmunol; 1992 Sep; 40(1):71-80. PubMed ID: 1387655
[TBL] [Abstract][Full Text] [Related]
16. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
[TBL] [Abstract][Full Text] [Related]
17. Effects of two convulsant beta-carboline derivatives, DMCM and beta-CCM, on regional neurotransmitter amino acid levels and on in vitro D-[3H]aspartate release in rodents.
Chapman AG; Cheetham SC; Hart GP; Meldrum BS; Westerberg E
J Neurochem; 1985 Aug; 45(2):370-81. PubMed ID: 2861248
[TBL] [Abstract][Full Text] [Related]
18. Quinolinic acid stimulates luteinizing hormone secretion in female rats: evidence for involvement of N-methyl-D-aspartate-preferring receptors.
Johnson MD; Whetsell WO; Crowley WR
Exp Brain Res; 1985; 59(1):57-61. PubMed ID: 2990984
[TBL] [Abstract][Full Text] [Related]
19. [Selective anticonvulsive action of N-substituted imidazole-4,5-dicarboxylic acids against quinolinic acid].
Ryzhov IV; Lapin IP; Piotrovskiĭ LB; Aleksandrova IIa
Biull Eksp Biol Med; 1988 Jul; 106(7):64-7. PubMed ID: 2969757
[TBL] [Abstract][Full Text] [Related]
20. Excitatory neurotransmission within substantia nigra pars reticulata regulates threshold for seizures produced by pilocarpine in rats: effects of intranigral 2-amino-7-phosphonoheptanoate and N-methyl-D-aspartate.
Turski L; Cavalheiro EA; Turski WA; Meldrum BS
Neuroscience; 1986 May; 18(1):61-77. PubMed ID: 3016600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
